YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Evaluation of Serum Ghrelin, Nesfatin-1, Irisin, and Vasoactive Intestinal Peptide Levels in Temporal Lobe Epilepsy Patients With and Without Drug Resistance: a Cross-Sectional Study

dc.authorid Ergul Erkec, Ozlem/0000-0001-5275-6254
dc.authorid Komuroglu, Ahmet Ufuk/0000-0002-0371-9251
dc.authorid Kara, Mehmet/0000-0002-8864-9706
dc.authorscopusid 57193334079
dc.authorscopusid 37087441500
dc.authorscopusid 57203863080
dc.authorscopusid 7006159432
dc.authorscopusid 55394375700
dc.authorscopusid 13005120600
dc.authorwosid Komuroglu, Ahmet/R-4769-2019
dc.authorwosid Erkec, Ozlem/A-2042-2017
dc.authorwosid Kara, Mehmet/F-4040-2011
dc.contributor.author Erkec, Ozlem Ergul
dc.contributor.author Milanlioglu, Aysel
dc.contributor.author Komuroglu, Ahmet Ufuk
dc.contributor.author Kara, Mehmet
dc.contributor.author Huyut, Zubeyir
dc.contributor.author Keskin, Siddik
dc.date.accessioned 2025-05-10T17:10:17Z
dc.date.available 2025-05-10T17:10:17Z
dc.date.issued 2021
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Erkec, Ozlem Ergul; Kara, Mehmet] Van Yuzuncu Yil Univ, Fac Med, Dept Physiol, Van, Turkey; [Milanlioglu, Aysel] Van Yuzuncu Yil Univ, Fac Med, Dept Neurol, Van, Turkey; [Komuroglu, Ahmet Ufuk] Van Yuzuncu Yil Univ, Van Vocat Higher Sch Healthcare Studies, Van, Turkey; [Huyut, Zubeyir] Van Yuzuncu Yil Univ, Fac Med, Dept Biochem, Van, Turkey; [Keskin, Siddik] Van Yuzuncu Yil Univ, Fac Med, Dept Biostat, Van, Turkey en_US
dc.description Ergul Erkec, Ozlem/0000-0001-5275-6254; Komuroglu, Ahmet Ufuk/0000-0002-0371-9251; Kara, Mehmet/0000-0002-8864-9706 en_US
dc.description.abstract OBJECTIVE: Epilepsy is a common disorder that affects the nervous systems of 1% of worldwide population. In epilepsy, one-third of patients are unresponsive to current drug therapies and develop drug-resistant epilepsy. Alterations in ghrelin, nesfatin-1, and irisin levels with epilepsy were reported in previous studies. Vasoactive intestinal peptide is among the most common neuropeptides in the hippocampus, which is the focus of the seizures in temporal lobe epilepsy. However, there is also lack of evidence of whether these four neuropeptide levels are altered with drug resistant temporal lobe epilepsy or not. The aim herein was the evaluation of the serum levels of nesfatin-1, ghrelin, irisin, and Vasoactive intestinal peptide in drug-resistant temporal lobe epilepsy patients and temporal lobe epilepsy (TLE) without drug resistance, and to compare them to healthy controls. METHODS: This cross-sectional study group included 58 temporal lobe epilepsy patients (24 with drug resistant temporal lobe epilepsy and 34 with temporal lobe epilepsy who were not drug-resistant) and 28 healthy subjects. Nesfatin-1, ghrelin, irisin, and Vasoactive intestinal peptide serum levels were determined using enzyme-linked immunosorbent assay. RESULTS: The serum ghrelin levels of patients with drug resistant temporal lobe epilepsy were seen to have significantly decreased when compared to those of the control group (p<0.05). Serum nesfatin-1, vasoactive intestinal peptide, and irisin levels were seen to have decreased in the drug resistant temporal lobe epilepsy group when compared to those of the control and temporal lobe epilepsy groups; however, the difference was non-significant (p>0.05). CONCLUSIONS: The results herein suggested that ghrelin might contribute to the pathophysiology of drug resistant temporal lobe epilepsy. However, further studies are needed to confirm this hypothesis. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1590/1806-9282.67.02.20200521
dc.identifier.endpage 212 en_US
dc.identifier.issn 1806-9282
dc.identifier.issue 2 en_US
dc.identifier.pmid 34406243
dc.identifier.scopus 2-s2.0-85113335873
dc.identifier.scopusquality Q2
dc.identifier.startpage 207 en_US
dc.identifier.uri https://doi.org/10.1590/1806-9282.67.02.20200521
dc.identifier.uri https://hdl.handle.net/20.500.14720/7390
dc.identifier.volume 67 en_US
dc.identifier.wos WOS:000686262400011
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Assoc Medica Brasileira en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Ghrelin en_US
dc.subject Neuropeptides en_US
dc.subject Drug Resistant Epilepsy en_US
dc.subject Vasoactive Intestinal Peptide en_US
dc.title Evaluation of Serum Ghrelin, Nesfatin-1, Irisin, and Vasoactive Intestinal Peptide Levels in Temporal Lobe Epilepsy Patients With and Without Drug Resistance: a Cross-Sectional Study en_US
dc.type Article en_US

Files